Ablacon Company

Ablacon is a provider of AI-guided atrial fibrillation therapies.

Founded Date: 2015
Last Funding Type: Post-IPO Equity
Headquarters: Wheat Ridge, Colorado, United States
Investors Number: 7
Technology: ['BioTech & HealthTech']
Industry: Med Tech
Estimated Revenue: $50M to $100M
Investor Type: contact@ablacon.com
Total Funding: $6.8B